Cite

HARVARD Citation

    Glintborg, B. et al. (2018). Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care. Scandinavian journal of rheumatology. pp. 418-421. [Online]. 
  
Back to record